Development of an Individualized Immune Prognostic Signature for Clear Cell Renal Cell Carcinoma through the Identification of Differential Immune Genes

Figure 1

Identification of the immunophenotypes and tumor microenvironments of samples from patients with clear cell renal cell carcinoma (ccRCC). Heatmap of the immune characteristics and tumor microenvironment in the (a) TCGA and (b) E-MTAB-1980 cohorts determined by the ssGSEA algorithm. Consensus clustering analysis, distribution of immune score, stromal score, and tumor purity of the low- and high-immunity groups in the (c–e) TCGA and (f–h) E-MTAB-1980 cohorts. Differences in immunogenicity between high-immunity and low-immunity groups in (i) TCGA and (j) E-MTAB-1980 cohorts. ; ns: no significance.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)